Arcus Biosciences, Inc.RCUS
Close of Friday, October 23, 2026 · Arcus Biosciences, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$18.54
vs its Pivot
-25.1%
OnlyAlpha Score
25
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -26.0% | -22.2% | +10.4% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| Baker Bros. Advisors | 0.1% of holdings |
Suppliers, customers and partners
Partners and deals
| Gilead Sciences | oncology collaboration |
From the companies' own annual reports filed with the SEC.
Get RCUS in your free daily emailAfter every close: whether RCUS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track RCUS free → Full Stock check
Track RCUS free → Full Stock check